Main Logo

Pushing the Treatment Landscape Forward: Real-World Radioligand Therapy Assessment and Management

By Joelle Hamilton, MD, Katy Beckermann, MD, PhD, Yu-Wei Chen, MD, MS, Kerry Schaffer, MD - Last Updated: October 18, 2024

Drs. Joelle Hamilton, Katy Beckermann, Yu-Wei Chen, and Kerry Schaffer discuss the evolving landscape of advanced prostate cancer treatment in the second part of their insightful discussion. They explore the challenges and innovations in managing patients using PSMA-targeted therapies, radioligand treatments, and remote patient care, while highlighting the importance of collaboration between academic and community centers, the use of multidisciplinary tumor boards, and strategies to refine patient selection for advanced therapies.

Watch the third part of this series: Imaging, Timing Considerations, and Creating Criteria in the Academic vs Community Setting

Post Tags:Roundtable RLT